BLCO · XBRL financial data
Bausch & Lomb financial statements, every fiscal year
The same tables from 4 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (BLCO's year ends in late December)
| In millions of dollars | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|
| Revenue from contracts with customers | 3,768 | 4,146 | 4,791 | 5,101 |
| Selling, general and administrative | 1,478 | 1,736 | 2,082 | 2,234 |
| Other operating income (expense) | (13) | (74) | (44) | (75) |
| Operating income (loss) | 207 | 130 | 162 | 113 |
| Interest income | 6 | 15 | 15 | 12 |
| Interest expense | 146 | 283 | 399 | 421 |
| Other income (expense) | (13) | (74) | — | — |
| Income tax expense (benefit) | 58 | 82 | 71 | 35 |
| Net income (loss) | 6 | (260) | (317) | (360) |
| Earnings per share, basic USD per share | 0.02 | (0.74) | (0.90) | (1.02) |
| Earnings per share, diluted USD per share | 0.02 | (0.74) | (0.90) | (1.02) |
| Weighted average shares, basic millions of shares | 350 | 351 | 352 | 354 |
| Weighted average shares, diluted millions of shares | 350 | 351 | 352 | 354 |
Balance sheet
CSVFiscal years (BLCO's year ends in late December)
| In millions of dollars | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | 354 | 331 | 305 | 383 |
| Inventory | 628 | 1,028 | 1,036 | 976 |
| Prepaid and other current assets | 405 | 541 | 410 | 383 |
| Total current assets | 2,137 | 2,742 | 2,788 | 2,977 |
| Property and equipment, net | 1,300 | 1,390 | 1,485 | 1,762 |
| Right-of-use asset | 119 | 114 | 151 | 160 |
| Goodwill | 4,507 | 4,575 | 4,523 | 4,758 |
| Total assets | 11,144 | 13,442 | 13,469 | 14,022 |
| Accounts payable | 370 | 522 | 389 | 388 |
| Accrued liabilities | 901 | 1,027 | 1,309 | 1,493 |
| Current portion of long-term debt | 25 | 30 | 40 | 28 |
| Total current liabilities | 1,296 | 1,579 | 1,738 | 1,920 |
| Long-term debt | 2,411 | 4,532 | 4,744 | 5,020 |
| Lease liability, non-current | 92 | 87 | 120 | 125 |
| Total liabilities | 4,043 | 6,522 | 6,925 | 7,503 |
| Retained earnings (accumulated deficit) | 6 | (254) | (571) | (931) |
| Total stockholders' equity | 7,033 | 6,850 | 6,473 | 6,448 |
| Total liabilities and equity | 11,144 | 13,442 | 13,469 | 14,022 |
| Common shares outstanding (cover page) millions of shares | 350 | 351 | 352 | 354 |
Cash flows
CSVFiscal years (BLCO's year ends in late December)
| In millions of dollars | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|
| Net income (loss) | 6 | (260) | (317) | (360) |
| Stock-based compensation | 62 | 74 | 92 | 149 |
| Net cash from operating activities | 345 | (17) | 232 | 283 |
| Purchases of property and equipment | 175 | 181 | 291 | 349 |
| Net cash from investing activities | (215) | (2,109) | (412) | (455) |
| Proceeds from long-term debt | 2,440 | 2,276 | 631 | 3,357 |
| Repayments of long-term debt | 13 | 161 | 430 | 3,096 |
| Net cash from financing activities | 81 | 2,078 | 178 | 225 |
| Net change in cash | 203 | (46) | (18) | 81 |
Compare with peers
SIC 3851 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3851 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| Bausch & Lomb | 513 | 1,375 | 233* | 357.5M | 10-QSep 30, 2026 |
| RxSight | 67 | 25 | 45* | 41.9M | 10-QSep 30, 2026 |
| Staar Surgical | 149 | 94 | 20* | 50.1M | 10-QJul 3, 2026 |
| National Vision Holdings | 36 | 499 | 8.1* | 79.1M | 10-QJul 4, 2026 |
| Warby Parker | 293 | 236 | 30* | not reported | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.